We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Peters Alexander has been assisting clients through the H1B Visa process since 2019.

As of 2022, Peters Alexander has succesfully submitted and recieved certification for 217 cases.

Peters Alexander is located in Boston, MA, and has represented 46 employers for the H1B Visa Process

234
Cases Handled
217
Cases Certified
92.74%
Approval

Cases Handled by Peters Alexander

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-18039-989228 CERTIFIED Sales Engineers Electric Lighting Equipment Manufacturing Energetiq Technology Inc 2018
I-200-17018-602136 CERTIFIED Public Relations Specialists Computer Terminal And Other Computer Peripheral Equipment Manufacturing Ingenico Inc 2017
I-200-17054-059327 CERTIFIED Graphic Designers Jewelry And Silverware Manufacturing Zero Porosity Casting Inc 2017
I-200-19163-997274 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Crispr Therapeutics Inc 2019
I-200-19109-308558 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Moderna Inc 2019
I-200-19077-861365 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Moderna Inc 2019
I-200-19065-957299 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Crispr Therapeutics Inc 2019
I-200-19065-476052 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Foghorn Therapeutics Inc 2019
I-200-19065-374055 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Crispr Therapeutics Inc 2019
I-200-19064-801043 CERTIFIED Biological Technicians Research And Development In The Physical Engineering And Life Sciences Rubius Therapeutics Inc 2019